Multiply Labs to Bring "Physical AI" Robotics Technology to Advanced Biomanufacturing With NVIDIA

Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA's open ...

Converge Bio raises $25M to bring generative AI drug discovery to every biotech and pharmaceutical company

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

Exosome Research Market Projected to Reach US$ 2,491.42 Million by 2035, Supported by Expanding Therapeutic Development Pipelines | Astute Analytica

Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.

Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery

Illumina, Inc. (NASDAQ: ILMN) today introduced the world's largest genome-wide genetic perturbation dataset, being built to ...

86% Fake—100% Admissible? Rethinking Evidence in the AI Era

Courts are increasingly confronting AI-generated and AI-manipulated evidence land on their dockets. But with innovation comes ...
EuropaWire

LSEG Introduces New Trade Surveillance Solutions to Enhance Compliance and Reduce Operational Risk

LSEG has launched Trade Surveillance, a new service designed to help financial institutions identify and investigate potential market abuse and financial crime more efficiently. Now live with ...
EuropaWire

Bechtle Expands European PLM Footprint with Acquisition of Hungary’s Leading SOLIDWORKS Partner EuroSolid

Bechtle AG has strengthened its European PLM presence by acquiring EuroSolid Zrt., Hungary’s largest SOLIDWORKS reseller and a long-standing partner of the local manufacturing industry. Founded in ...